3190 results for «288»

Filter By

3190 results

Patient-tailored treatment for bicuspid valve

14 Feb 2026 – From PCR Tokyo Valves 2026

Delve into patient-tailored treatment strategies for bicuspid aortic valve stenosis, focusing on evidence-based valve selection and sizing for TAVI candidates. This session reviews current device options, procedural planning considerations, and case studies illustrating the use of balloon-expanding and self-expanding valves, emphasizing challenges posed by unfavourable bicuspid...

Patient-tailored treatment for bicuspid valve

Mitral TEER masterclass

14 Feb 2026 – From PCR Tokyo Valves 2026

Delve into the mitral TEER masterclass focusing on unique anatomical challenges encountered in Asian populations. This session presents complex case studies illustrating device strategies and practical techniques aimed at minimizing complications and optimizing procedural outcomes in anatomically challenging scenarios.

Mitral TEER masterclass

All you need to know about redo TAVI

15 Feb 2026 – From PCR Tokyo Valves 2026

This comprehensive session on redo Transcatheter Aortic Valve Implantation (TAVI) covers critical aspects beyond coronary obstruction risk, including detailed pre-procedural analysis, valve sizing, and innovative procedural techniques such as leaflet modification and optimal angle placement. Post-procedural considerations like antithrombotic therapy and patient-prosthesis mismatch are also thoroughly...

All you need to know about redo TAVI

Contemporary approach in the treatment of calcified coronary artery disease

28 Feb 2026 – From Euro4C Annual Meeting 2026

Adopt a contemporary approach to managing calcified coronary artery disease by leveraging high-definition IVUS for lesion assessment and morphology evaluation. Learn to tailor calcium modification strategies based on IVUS findings and combine available tools to optimize treatment outcomes according to patient and lesion profiles.

Contemporary approach in the treatment of calcified coronary artery disease

Welcome to the Euro4C Annual Meeting 2026

27 Feb 2026 – From Euro4C Annual Meeting 2026

This introductory session sets the stage for a comprehensive exploration of interventional cardiology topics, providing attendees with an overview and framework for the upcoming educational content.

Welcome to the Euro4C

Interventional management of an aortic root fistula after aortic-valve endocarditis

25 Jan 2021

This is a 44-year old male patient with an aortic root fistula to the right heart after past infective aortic valve endocarditis. Interventional shunt occlusion was successfully performed using a transcatheter closure device.

Interventional aortic root fistula closure

RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis

01 Sep 2024

While Chiara De Biase interviews Helene Eltchaninoff about the RHEIA trial results, which she presented at the ESC Congress 2024 in London, Panos Xaplanteris shares his perspective on the trial, offering all the essential information and key takeaways you need for your practice!

Author

Chiara De Biase

Author

Helene Eltchaninoff
Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
RHEIA

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Nicola Ryan

Author

Nicola Ryan
10-Year Outcomes of Multicenter Randomized Controlled BEST Trial: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel CAD

TRI.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation

31 Aug 2024

Alex Sticchi provides his take on the results of the TRI.FR trial presented by Erwan Donal at the ESC Congress 2024 in London.

Alessandro Sticchi

Author

Alessandro Sticchi
Tri.fr trial
Didn’t find what you were looking for?